StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PG$139.44-0.60%
Fair $139.44+0.0%

PG

The Procter & Gamble Company

Consumer Defensive / Household & Personal ProductsNYSE

$139.44

-0.85 (-0.60%)

Fairly Valued+0.0%Fair Value $139.44Fund rank 38/100 · Data gapFallback financials|
SA 28/D
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 21% · confianza 25%

FCF escenarios

weak_data · normalized FCF $14.0B · quality 79.7/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 89/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

28/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 18Warnings: 0unknown: 18
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · PGLocal privado en este navegador · The Procter & Gamble Company
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$324.7B

P/E

20.4x

↑

EV/EBITDA

15.4x

↑

ROE

30.7%

↑

Gross Margin

51.2%

↑

Debt/Equity

0.68

↑
52-Week Range$139
$138$169

TradingView lightweight chart

PG price, volumen y niveles de valoración

Último $139.43Periodo +160.2%
Fair value: $139.44

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2008–2025 · 17 años de histórico normalizado

Revenue CAGR

+0.4%

FCF CAGR

+0.9%

FCF margin

16.7%

FCF / Net income

0.88x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $84.28B · net income $15.97B · FCF $14.04B

2008-FY → 2025-FY

Gross margin

51.2%— pts

Operating margin

24.3%+4.1% pts

Net margin

19.0%+3.7% pts

FCF margin

16.7%+1.6% pts
MetricTTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Income Statement
Revenue$84.28B$84.28B$84.04B$82.01B$80.19B$76.12B$70.95B$67.68B$66.83B$65.06B$65.30B$70.75B$74.40B$80.12B$82.01B$81.10B$77.57B$76.69B$79.26B
Net Income$15.97B$15.97B$14.88B$14.65B$14.74B$14.31B$13.03B$3.90B$9.75B$15.33B$10.51B$7.04B$11.64B$11.31B$10.76B$11.80B$12.74B$13.44B$12.07B
EBITDA$23.92B$23.92B$22.58B$21.82B$21.24B$20.72B$18.72B$8.31B$16.20B$16.59B$16.52B$14.18B$17.05B$16.80B$16.24B$18.33B$18.84B$18.46B$19.14B
EPS6.516.516.025.905.815.504.961.433.675.593.692.444.013.863.663.934.114.263.64
Gross Margin51.2%51.2%51.4%47.9%47.4%——————————————
Operating Margin24.3%24.3%23.7%22.1%22.2%23.6%22.1%8.1%20.0%21.2%20.6%15.6%18.7%17.2%15.9%19.1%20.3%20.0%20.2%
Net Margin19.0%19.0%17.7%17.9%18.4%18.8%18.4%5.8%14.6%23.6%16.1%9.9%15.6%14.1%13.1%14.5%16.4%17.5%15.2%
Balance Sheet
Debt/Equity0.680.680.660.760.69——————————————
Current Ratio0.730.73—————————————————
Cash Flow
Free Cash Flow$14.04B$14.04B$16.52B$13.79B$13.57B$15.58B$14.33B$11.89B$11.15B$9.37B$12.12B$10.87B$10.11B$10.87B$9.32B$10.02B$13.06B$11.68B$11.96B
Returns
ROE30.7%30.7%29.6%31.3%31.6%——————————————
Valuation
P/E20.3620.3627.4425.2224.96——————————————
EV/EBITDA15.3915.3919.1418.1818.52——————————————
P/B6.586.588.127.907.90——————————————
Growth & Yield
Revenue Growth0.3%0.3%2.5%2.3%—7.3%4.8%1.3%2.7%-0.4%-7.7%-4.9%-7.1%-2.3%1.1%4.6%1.1%-3.2%—
EPS Growth8.1%8.1%2.0%1.5%—10.9%246.9%-61.0%-34.3%51.5%51.2%-39.2%3.9%5.5%-6.9%-4.4%-3.5%17.0%—
Dividend Yield3.0%3.0%—————————————————

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

23.9%

exigente

EPS terminal req.

$12.37

Spread vs growth

-15.7%

5Y implied EPS CAGR

18.1%

exigente

EPS terminal req.

$14.97

Spread vs growth

-10.0%

10Y implied EPS CAGR

14.0%

razonable

EPS terminal req.

$24.11

Spread vs growth

-5.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -13.9%

Total return

-13.9%

Start / end P/E

27.9x → 21.4x

EPS bridge

6.02 → 6.51

Residual

-1.9%

EPS growth+8.1%
Multiple rerating-23.1%
Dividend+3.0%
Residual / FX / buybacks / cross-term-1.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.